Personalized Integrative Oncology: Targeted Approaches for Optimal Outcomes

个性化综合肿瘤学：实现最佳结果的针对性方法

基本信息

批准号：
8838465
负责人：
Lorenzo Cohen
金额：
$ 0.8万
依托单位：
UNIVERSITY OF TX MD ANDERSON CAN CTR
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-09-01 至 2015-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8838465
关键词：
Academy Address Advocate Affect American Area Basic Science British Columbia Canada Case Study Clinical Clinical Research Clinical Sciences Clinical Trials Collaborations Communities Data Development Educational workshop Epigenetic Process Fostering Future Growth Guidelines Health Professional Healthcare Institution Integrative Medicine International Joints Knowledge Learning Life Style Malignant Neoplasms Oncologist Oral Outcome Palliative Medicine Patient Care Patient advocacy Patients Prevention Recording of previous events Recovery Research Research Methodology Research Personnel Role Sleep Disorders Societies Stream Stress Targeted Research Technology Texas Therapeutic Time Training United States Universities University of Texas M D Anderson Cancer Center Work base career clinical practice dissemination research evidence base experience hospice environment improved innovation knowledge translation lectures malignant breast neoplasm meetings member mindfulness multidisciplinary next generation oncology posters programs public health relevance stem symposium symptom management tumor

项目摘要

DESCRIPTION (provided by applicant): The Society for Integrative Oncology (SIO) 11th International Conference, entitled "Personalized Integrative Oncology: Targeted Approach For Optimal Outcomes", aims to critically examine recent advances in research that have the potential to improve the practice of integrative oncology as a contemporary health care option. This conference will focus on disseminating important findings from integrative oncology research that are taking a targeted approach including both basic and clinical science, to ultimately improve the outcome of patient care. The overarching aim of the SIO 2014 conference is to highlight the unique trajectory of targeted integrative oncology research, knowledge development, and its implication in integrative oncology. The 2 and 1/2-day meeting is being held in Houston and is co-hosted by the University of Texas MD Anderson Cancer Center. The 2014 SIO conference program contains three keynote lectures that will directly address current research in targeted integrated oncology including the: 1) The role of personalized integrative oncology in the prevention, treatment and recovery from cancer; 2) The impact of stress on patients with cancer; and 3) The intersection of sleep disorders and cancer. In addition to keynote lectures, the conference will include: four moderated plenary panels are planned covering: 1) personalized integrative oncology; 2) the role of lifestyle and epigenetics in the context of cancer; 3) a joint session with AAHPM to tackle targeted symptom management; and 4) breast cancer guidelines. The conference will also have two multidisciplinary integrative tumor boards; two preconference workshops to focus on clinical research and clinical practice relevant to innovated integrative oncology; four didactic and experiential workshops; a public lecture on mindfulness practices in integrative oncology; and patient advocacy and trainee streams. Presentations of original research, in various topics related to targeted integrated oncology, including clinical trials, basic science, and research methodology, will be solicited from members of the national and international research communities for 45 oral and up to 80 poster presentations. The conference aims are to: 1) Create an international venue in which researchers, clinicians and patient advocates can discuss the current evidence regarding targeted integrative oncology research and practices and enhance their understanding the advantage and challenge of this particular field; 2) Foster dialogue, collaboration and networking among researchers, health professionals, and patient advocates, facilitating future research and knowledge using targeted strategies in the field of integrative oncology; and 3) Assist in the training of trainees, early career investigators and patient advocates in creating, interpreting an disseminating evidence-based integrative oncology research. Ultimately, it is our hope that the renewed knowledge and clinical practice on targeted integrative oncology obtained from this conference will improve the outcome of patient care by integrative oncologist and practitioners.

描述（由申请人提供）：综合肿瘤学协会（SIO）第 11 届国际会议，题为“个性化综合肿瘤学：最佳结果的目标方法”，旨在批判性地审查有潜力改善综合肿瘤学实践的最新研究进展肿瘤学作为当代医疗保健选择。本次会议将重点传播综合肿瘤学研究的重要发现，这些研究采取有针对性的方法，包括基础科学和临床科学，以最终改善患者护理的结果。 SIO 2014 会议的总体目标是强调针对性的综合肿瘤学研究、知识发展的独特轨迹及其对综合肿瘤学的影响。为期 2 天又 1/2 天的会议在休斯顿举行，由德克萨斯大学 MD 安德森癌症中心共同主办。 2014 年 SIO 会议议程包含三场主题演讲，将直接讨论靶向整合肿瘤学的当前研究，包括： 1) 个性化整合肿瘤学在癌症预防、治疗和康复中的作用； 2）压力对癌症患者的影响； 3) 睡眠障碍与癌症的交叉点。除了主题演讲外，会议还将包括：计划举行四个主持的全体小组讨论，涵盖：1）个性化综合肿瘤学； 2）生活方式和表观遗传学的作用癌症的背景； 3) 与 AAHPM 召开联合会议，解决有针对性的症状管理问题； 4) 乳腺癌指南。会议还将设立两个多学科综合肿瘤委员会；两次会前研讨会，重点关注与创新综合肿瘤学相关的临床研究和临床实践；四个教学和体验研讨会；关于综合肿瘤学正念实践的公开讲座；以及患者倡导和实习生流。将从国内和国际研究界的成员那里征集与靶向整合肿瘤学相关的各种主题（包括临床试验、基础科学和研究方法）的原创研究报告，进行 45 场口头报告和最多 80 场海报报告。会议的目的是： 1) 创建一个国际场所，让研究人员、临床医生和患者权益倡导者可以讨论有关靶向综合肿瘤学研究和实践的当前证据，并增强他们对这一特定领域的优势和挑战的理解； 2) 促进研究人员、卫生专业人员和患者倡导者之间的对话、合作和网络，利用综合肿瘤学领域的有针对性的策略促进未来的研究和知识； 3) 协助培训学员、早期职业调查员和患者倡导者创建、解释传播循证综合肿瘤学研究。最终，我们希望从本次会议中获得的关于靶向综合肿瘤学的新知识和临床实践将改善综合肿瘤学家和从业人员对患者护理的结果。